Stanford University
Clinical research site in Stanford, California · 875 BLAKE WILBUR DRIVE, STANFORD, CA 94305-5847 · (650) 723-6171
Part of Stanford University
As of September 2026, 168 paid clinical trials are recruiting at Stanford University in Stanford, California. Active studies at this site cover conditions such as Autism Spectrum Disorder, Autism and Atrial Fibrillation. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Stanford University (168)
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Pompe Disease Registry Protocol
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
DALY II USA/ MB-CART2019.1 for DLBCL
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
AI-driven Total Parenteral Nutrition Platform
Radiocaine Safety Study
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
DFT383 in Pediatric Participants With Nephropathic Cystinosis
Study With [225Ac]Ac-FL-020 in mCRPC Participants
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
US National TOP Registry
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Body Clocks - Coordination of Peripheral and Central Oscillators
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
Early Introduction and Sustained Ingestion (EISI) Using Two Educational Opportunities in Infants
Preoperative Hemodialysis Timing in Patients With End-Stage Kidney Disease: The POD-ESKD Pilot Trial
Showing the 40 most relevant of 168 recruiting trials at this site. Browse all with filters →
Get new-trial alerts for Stanford University
We'll email you whenever a new clinical trial starts recruiting at this research site in Stanford, CA. Unsubscribe anytime.
More research sites in Stanford
- Stanford University School of Medicine (44 trials)
- Stanford University Medical Center (35 trials)
- Stanford Cancer Institute (12 trials)
- Stanford Health Care (9 trials)
- Stanford Medical Center (9 trials)
- Stanford Hospital and Clinics (8 trials)
- Stanford Hospital (6 trials)
- Stanford Cancer Center (5 trials)
- Lucile Packard Children's Hospital (4 trials)
- Stanford (4 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Stanford, CA · California clinical trials